DSDaria I. Smirnova

Daria I. Smirnova

*This is an algorithmically generated author record based on publicly available information.

Daria I. Smirnova has a total of 62 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Virulence and tissue tropism of different epidemiologically significant SARS-CoV-2 variants for golden Syrian hamsters

    by Anastasiia V. Gracheva, Andrey O. Drokov, Daria I. Smirnova, Darya M. Khokhlova, Ekaterina R. Korchevaya, Andrey A. Pankratov, Galina V. Trunova, Varvara A. Khokhlova, Maria S. Vorontsova, Irina A. Leneva, et al.

    Introduction. Animal models for SARS-CoV-2 infection, reproducing the clinical features of COVID-19 in humans, are important tools for studying the pathogenesis of the disease, transmission of the pathogen and are indispensable for testing antiviral drugs and vaccines. The aim of the study was to assess the virulence and tissue tropism for golden Syrian hamsters of SARS-CoV-2 strains belonging to different epidemiologically significant variants: Wuhan-like, Delta, Omicron BA.1.1 and Omicron BA.5.2. Materials and methods. Hamsters were intranasally infected with different SARS-CoV-2 strains. Virulence and tissue tropism of SARS-CoV-2 strains were assessed by comparing the dynamics of weight, viral load in organs and histopathological changes in lungs in infected and uninfected animals. Results. The Wuhan-like Dubrovka strain had the greatest virulence for hamsters, which was manifested by the development of severe pneumonia and a delay in weight gain by 14.6%, high virus content in the lungs, nasal passages and brain — 6.2, 5,9 and 3.7 lg TCID50/ml of homogenate, respectively. Presumably, it was the infection of the Wuhan-like virus of the central nervous system that negatively affected the weight and general condition of the animals. When hamsters were infected with viruses belonging to the Delta and Omicron variants, the observed minor weight loss in animals was uninformative, so indicators such as lung histopathology, viral load in the lungs, nasal passages, heart and other organs played a decisive role in assessing the virus pathogenicity. A score assessment of lung histopathology was of particular value in assessing the severity of pneumonia, since it reduced subjectivity in evaluating the results of histological examination and provided a semi-quantitative assessment of the pathological process. Conclusion. Despite the revealed lower virulence for hamsters of viruses belonging to the Delta and Omicron variants compared to the ancestral Wuhan virus, this animal model for COVID-19 retains its value for conducting preclinical trials of antiviral drugs.


  • Open Access

    Antiviral Activity of Cytovir®-3 Against Human Rotavirus Infection Agent in vitro

    by E. B. Faizuloev, I. A. Leneva, V. S. Smirnov, D. I. Smirnova, A. V. Gracheva, E. R. Korchevaya, D. M. Khokhlova, T. A. Kudryavtseva, S. V. Petlenko, V. A. Zaplutanov

    Introduction. Rotavirus infection causes more than 250 million episodes of acute gastroenteritis annually, of which approximately 130,000 cases in children under 5 years of age are fatal. In this regard, the search for drugs for the treatment of rotavirus infection seems extremely relevant.The aim of the research was to evaluate the antiviral activity of Cytovir®-3 against human rotavirus on a cellular infection model.Material and methods. The objects of the study were a mixture of active ingredients and individual components, identical in composition and ratio, contained in Cytovir®-3. The study was carried out using a monkey kidney cell culture MA-104 and a laboratory strain of human group A rotavirus — 568, genotype G3P. Cultural, virological, molecular biological and statistical methods were used during the study.Results and discussion. Analysis of the survival of MA-104 cells in the presence of Cytovir®-3 showed that in the concentration range from 100 to 200 µg/ml, the drug reproducibly exhibited antiviral activity, which was expressed in increased cell survival compared to the viral control. Cytovir®-3 in a non-toxic concentration of 150 µg/ml suppressed the reproduction of rotavirus by 1.0-2.0 lg СC₅₀/ml with various schemes of introduction into cell culture at all periods of observation, which was accompanied by a significant decrease in the concentration of viral RNA and a cytoprotective effect.

  • Open Access

    Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern

    by Evgeny B. Faizuloev, Anastasiia V. Gracheva, Ekaterina R. Korchevaya, Yulia I. Ammour, Daria I. Smirnova, Darya M. Khokhlova, Andrey O. Drokov, Andrey A. Pankratov, Galina V. Trunova, Varvara A. Khokhlova, et al.

    Introduction. Despite the end of the COVID-19 pandemic, the problem of vaccine prevention of this disease appears highly relevant. The emergence and widespread distribution of the Omicron SARS-CoV-2 variant of concern (VOC) and its sublineages has dramatically reduced the efficacy of vaccination. The possible approach to solving this problem is to develop a nasal live attenuated vaccine capable of activating humoral, mucosal, and cell-mediated immunity, providing a prolonged immune response and cross-protection against different VOCs. The aim of the study was to determine the immunization efficacy with attenuated cold-adapted Wuhan-like SARS-CoV-2 D-D2 strain against homologous and heterologous challenges. Materials and methods. The study was conducted on an animal model of coronavirus pneumonia in golden Syrian hamsters. The efficacy of immunization was assessed by comparing the dynamics of weight, viral load in organs and histopathological changes in the lungs in immunized and unimmunized animals. Results. Single intranasal immunization of golden Syrian hamsters with D-D2 strain showed its high immunogenicity: seroconversion was evident in all immunized animals. Wuhan-like D-D2 strain provides highly effective protection of hamsters against the development of productive infection and pneumonia when challenged both with ancestral virus and heterologous strains related to Delta (AY.122) and Omicron (sublineages BA.1.1 and BA.5.2) variants. Conclusion. SARS-CoV-2 attenuation is a promising strategy for the development of a highly effective nasal live COVID-19 vaccine.


  • Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity

    by Evgeny Faizuloev, Anastasiia Gracheva, Ekaterina Korchevaya, Daria Smirnova, Roman Samoilikov, Andrey Pankratov, Galina Trunova, Varvara Khokhlova, Yulia Ammour, Olga Petrusha, et al.


  • Open Access

    Comparative study of Wuhan-like and omicron-like variants of SARS-CoV-2 in experimental animal models

    by I A Leneva, D I Smirnova, N P Kartashova, A V Gracheva, A V Ivanina, E A Glubokova, E R Korchevaya, A A Pancratov, G V Trunova, V A Khokhlova, et al.

    Introduction. The variability of SARS-CoV-2 appeared to be higher than expected, the emergence of new variants raises concerns. The aim of the work was to compare the pathogenicity of the Wuhan and BA.1.1/Omicron variants in BALB/c mice and Syrian hamsters. Materials and methods. The study used strains of SARS-CoV-2: Dubrovka phylogenetically close to Wuhan-Hu-1, and LIA phylogenetically close to Omicron, BALB/c mice, transgenic mice B6.Cg-Tg(K18-ACE2)2Prlmn/HEMI Hemizygous for Tg(K18-ACE2)2Prlmn, Syrian golden hamsters. Animals were infected intranasally, pathogenicity was estimated by a complex of clinical, pathomorphological and virological methods. Results. Comparative studies of SARS-CoV-2 Dubrovka and LIA strains on animal models demonstrated their heterogeneous pathogenicity. In parallel infection of BALB/c mice with Dubrovka and LIA variants, the infection proceeded without serious clinical signs and lung damage. Infection with the LIA strain resulted to a systemic disease with a high concentration of viral RNA in the lungs and brain tissues of animals. The presence of viral RNA in mice infected with the Dubrovka strain was transient and undetectable in the lungs by day 7 post-infection. Unlike the mouse model, in hamsters, the Dubrovka strain had a greater pathogenicity than the LIA strain. In hamsters infected with the Dubrovka strain lung lesions were more significant, and the virus spread through organs, in particular in brain tissue, was observed. In hamsters infected with the LIA strain virus was not detected in brain tissue. Conclusion. The study of various variants of SARS-CoV-2 in species initially unsusceptible to SARS-CoV-2 infection is important for monitoring zoonotic reservoirs that increase the risk of spread of new variants in humans.


  • Open Access

    Attenuation markers of cold-adapted SARS-CoV-2 variants

    by Anastasiia V. Gracheva, Ekaterina R. Korchevaya, Roman V. Samoilikov, Daria I. Smirnova, Irina А. Leneva, Artem A. Poromov, Andrey А. Pankratov, Galina V. Trunova, Varvara А. Khokhlova, Firaya G. Nagieva, et al.

    BACKGROUND: Unprecedented anti-epidemic measures and the widespread use of vaccines against COVID-19 have reduced the rate of hospitalization and mortality from the disease, but have not stopped the SARS-CoV-2 pandemic spread. The development of live vaccines against COVID-19, capable of providing the formation of a long-term humoral and cellular immune response and cross-protection against new SARS-CoV-2 variants of concern, is relevant. Previously at the I.I. Mechnikov Research Institute of Vaccines and Sera SARS-CoV-2 cold-adapted (ca, cold-adapted) variants were obtained. This work is aimed to search for methodological approaches that allow in vitro screening studies to assess the attenuation (att) phenotype of ca SARS-CoV-2 variants. MATERIALS AND METHODS: The SARS-CoV-2 laboratory strain Dubrovka and its variants were cultured in Vero and Calu-3 cells. Quantitation of the virus was carried out by titration in Vero cells and by real-time RT-PCR. The attenuation (att) phenotype of SARS-CoV-2 variants was determined on an animal model of COVID-19 on Syrian hamsters. RESULTS: In experiments on Syrian hamsters, the presence of the att phenotype in the ca variants of the virus was established. Animals infected with virus ca variants had significantly less weight lost, had less viral load in the lungs and brain and less pronounced pathological changes in the lungs compared to infection with the virulent strain. In vitro experiments on Vero and Calu-3 cells revealed probable attenuation markers of the virus ca variants for syrian hamsters: (1) ability to reproduce at low temperature (ca phenotype); (2) inability to reproduce at 39 C (ts phenotype); (3) changes in the species and tissue specificity of the virus. CONCLUSIONS: The developed methodological approaches to the identification of SARS-CoV-2 attenuation markers are a valuable tool for monitoring the stability of the phenotype of candidate vaccine strains.


  • Open Access

    Biological characterization of cold-adapted SARS-CoV-2 variants

    by E. B. Faizuloev, E. R. Korchevaya, A. A. Gracheva, R. V. Samoilikov, D. I. Smirnova, O. S. Sokolova, G. S. Glukhov, A. V. Moiseenko, I. A. Leneva, F. G. Nagieva, et al.

    Introduction. The emergence of new epidemiologically significant variants of SARS-CoV-2 has shifted emphasis to development of a live vaccine, which would be able to provide protection against a wide range of antigenic variants of the virus. The aim of the study was to obtain SARS-CoV-2 variants attenuated through cold adaptation and to provide their biological characterization.Materials and methods. The Dubrovka laboratory strain of SARS-CoV-2 and its variants were cultured on Vero and Calu-3 cells. The virus quantification was performed by virus titration in Vero cells and by real-time reverse transcription-polymerase chain reaction. SARS-CoV-2 virions were analyzed using transmission electron microscopy. Genome sequences of the virus were identified by nanopore sequencing. The attenuation (att) phenotype of SARS-CoV-2 variants was identified using Syrian hamsters as an animal model for COVID-19. Results. Cold-adapted (ca) SARS-CoV-2 variants – Dubrovka-ca-B4 and Dubrovka-ca-D2 were produced by continued passaging of the Dubrovka strain in the Vero cell culture at the temperature being gradually decreased to 23ºC and by subsequent cloning. Up to 20 nucleotide substitutions and 18 amino acid substitutions were detected in genomes of ca-variants. Ca-variants, as distinct from the parent Dubrovka strain, actively replicated at 23ºC, while the Dubrovka-ca-D2 variant had a temperature-sensitive (ts) phenotype (did not replicate at 39ºC). Ca-variants of the virus replicated poorly at 37ºC in the Calu-3 human lung cell culture, which, along with the ts-phenotype, can be a marker of virus attenuation for humans. In the intranasally infected Syrian hamsters, ca-variants of the virus demonstrated an attenuation phenotype: they did not cause loss of appetite, fatigue, drowsiness, did not slow down weight gain, replicating much more slowly in the lungs and brain compared to the virulent Dubrovka strain. Conclusion. The obtained attenuated SARS-CoV-2 ca-variants, Dubrovka-ca-B4 and Dubrovka-ca-D2, should be studied further as candidate vaccine strains for a live attenuated vaccine against COVID-19.


  • Epstein–Barr Virus: Evaluation of gp350 and EBNA2 Gene Variability

    by T. V. Solomai, M. V. Malakhova, E. A. Shitikov, D. A. Bespyatykh, V. A. Veselovskii, T. A. Semenenko, D. I. Smirnova, A. V. Gracheva, E. B. Faizuloev

    Approximately 90% of the world’s population is infected with the Epstein–Barr virus (EBV). Damage to health and high economical costs require t

  • Epstein—Barr virus: evaluation of gp350 and EBNA2 gene variability

    by T.V. Solomay, M.V. Malakhova, E.A. Shitikov, D.A. Bespiatykh, V.A. Veselovsky, T.A. Semenenko, D.I. Smirnova, A.V. Gracheva, E.B. Fayzuloev

    Вирусом Эпштейна—Барр (ВЭБ) инфицировано около 90% населения планеты. Ущерб здоровью и высокие экономические потери требуют разработки вакцин против ВЭБ-инфекции. Вариабельность отдельных генов может повлиять на успех прививочной кампании и будет требовать динамического обновления антигенного состава вакцин. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка вариабельности генов gp350 и EBNA2 ВЭБ, выделенного из слюны персонала стоматологических клиник московского региона. МАТЕРИАЛ И МЕТОДЫ Биологические образцы (слюна) получены от 105 сотрудников четырех стоматологических клиник. Для образцов, содержащих ДНК ВЭБ, проводили амплификацию генов gp350 и EBNA2 методом нестед-ПЦР. Определение нуклеотидной последовательности гена gp350 осуществляли в ходе секвенирования. Построение филогенетического дерева максимального правдоподобия проводили по N-концевому фрагменту белка gp350, в качестве референсного генома использовали последовательность штамма B95-8. В филогенетический анализ дополнительно включены 222 образца ВЭБ из базы данных NCBI. РЕЗУЛЬТАТЫ Генотип по EBNA2 и полная последовательность гена gp350 были определены для 31 образца ДНК. Согласно филогенетическому анализу N-концевой последовательности белка gp350 исследуемых образцов и образцов из базы данных NCBI, представители российской популяции вируса были равномерно распределены по дереву. При этом 30 образцов относились к кладе Aa (A — генотип A по гену EBNA2; a — схожесть последовательности gp350 с B95-8 (NC_007605.1)), один — к кладе Bb (B — генотип B по гену EBNA2; b — схожесть gp350 с таковым у Jijoye (LN827800.1)). Для 30 российских образцов генотипа Aa было обнаружено 22 индивидуальных профиля и 16 уникальных мутаций. Среди персонала, работающего в тесном профессиональном контакте, обнаружены идентичные профили gp350. ЗАКЛЮЧЕНИЕ Выявленные особенности указывают на необходимость проведения дальнейшего филогенетического исследования образцов, отобранных на территории России, для разработки и внедрения вакцин и мониторинга их эффективности.


  • Open Access

    Adaptation of the MTT assay for detection of neutralizing antibodies against the SARS-CoV-2 virus

    by A. V. Gracheva, E. R. Korchevaya, A. M. Kudryashova, O. V. Borisova, O. A. Petrusha, D. I. Smirnova, I. N. Chernyshova, O. A. Svitich, V. V. Zverev, E. B. Faizuloev

    Introduction. The ability of SARS-CoV-2 antibodies to neutralize the virus is the primary indicator of their specific activity. The test for virus neutralizing antibodies (NAbs) is much needed in different biomedical studies.The aim of the study is to find optimum conditions for microscopic and spectrophotometric detection of SARSCoV-2 NAbs by inhibition of cytopathic effect (CPE) in cell cultures.Materials and methods. Blood sera collected from COVID-19 convalescent patients and healthy individuals (n = 96) were tested using the ELISA method. The SARS-CoV-2 coronavirus, Dubrovka strain (GenBank accession no. MW514307.1) was grown in culture medium of Vero cell line CCL-81 (ATCC). Real-time RT-PCR, ELISA, and Sanger sequencing were used for detection of the virus. The results of the neutralization test (NT) were assessed through the microscopic examination for CPE and by the methyl thiazolyl tetrazolium (MTT) assay.Results. SARS-CoV-2 was isolated from a COVID-19 patient and adapted to grow in cell culture. At a low dose of infection (MOI = 0.00001), the virus caused a pronounced CPE with the cell viability less than 3%, thus making it possible to assess NT results by CPE inhibition. The NT and ELISA-based comparative study of sera showed positive correlation between virus NAb titers and Nab titers to S-protein RBD (Spearman’s r = 0.714; p 0.001). The results of NAbs microscopic and spectrophotometric detection (the MTT assay) also demonstrated positive correlation (Spearman’s r = 0.963; p 0.05).Conclusion. The SARS-CoV-2 virus adapted to Vero cell culture served to develop a NAb titer assessment system, which can be used both in microscopic studies and for an MTT assay in spectrophotometric studies. The MTT assay provides automated reading of NT results, optimizes the statistical analysis of the obtained data, and minimizes subjectivity in assessment of results. Being a vital dye, MTT penetrates only viable cells, thus contributing to the reliability of the obtained results compared to other dyes.